Pretransplant removal of anti-HLA antibodies by plasmapheresis and continued suppression on cyclosporine-based therapy after heart-kidney transplant.
E Hodge(Cleveland Clinic), Daniel Cook(University of Dundee), Robert W. Stewart(Cleveland Clinic), Joseph V. Nally(Cleveland Clinic), Anna P. Koo(Cleveland Clinic), Robert E. Hobbs(Cleveland Clinic), Lynne Klingman(Cleveland Clinic)
PubMed
October 1, 1994
Cited by 23
Related Papers
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
High Prevalence of Coronary Atherosclerosis in Asymptomatic Teenagers and Young Adults
|Circulation|2001|681
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
|The Lancet Diabetes & Endocrinology|2019|330
Intravascular Ultrasound Evidence of Angiographically Silent Progression in Coronary Atherosclerosis Predicts Long-Term Morbidity and Mortality After Cardiac Transplantation
|Journal of the American College of Cardiology|2005|286
Serum Bicarbonate and Mortality in Stage 3 and Stage 4 Chronic Kidney Disease
|Clinical Journal of the American Society of Nephrology|2011|181